Advances in Integrated Antimicrobial Resistance Surveillance and Control Strategies in Asia-Pacific Economic Cooperation Economies: Assessment of a Multiyear Building Capacity Project.
APEC
antimicrobial resistance
high economies
low–middle economies
surveillance
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
29 Jul 2022
29 Jul 2022
Historique:
received:
26
04
2022
revised:
27
07
2022
accepted:
27
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) is a growing global health concern for both animal and public health, and collaborative strategies are needed to combat the threat. The level of awareness and funding for policies focused on reducing AMR varies between countries. The aim of this study was to compare the integrated surveillance systems for AMR in high and low-middle economies of the Asia-Pacific Economic Cooperation and determine whether there was any improvement from 2015 to 2018. We conducted a survey with a group of 21 countries at different development levels. Associations between the economic development level and the questions of AMR awareness and funding were established using Fisher's exact test. Improvements were identified where countries established public policies for integrated surveillance of AMR. High economies showed greater advancement in several topics related to AMR than low-middle economies. The survey revealed that there is a better understanding surrounding the implications of the emergence of AMR in human medicine than in veterinary medicine, agriculture, and food production. Our results show that countries enhanced overall AMR surveillance over the 4-year-period; however, more research is needed concerning these advances, especially in low-middle economies and the food production sector.
Identifiants
pubmed: 36009891
pii: antibiotics11081022
doi: 10.3390/antibiotics11081022
pmc: PMC9405055
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Asia-Pacific Economic Cooperation
ID : CTI 25 2014A (SCSC)
Organisme : Asia-Pacific Economic Cooperation
ID : CTI 24 2017A (SCSC)
Références
Crit Rev Microbiol. 2013 Feb;39(1):57-69
pubmed: 22639875
Sci Rep. 2019 Jul 5;9(1):9788
pubmed: 31278344
Int J Environ Res Public Health. 2013 Jun 28;10(7):2643-69
pubmed: 23812024
Int J Antimicrob Agents. 2021 Oct;58(4):106411
pubmed: 34371112
Trans R Soc Trop Med Hyg. 2017 Jun 1;111(6):255-260
pubmed: 29044373
Front Microbiol. 2016 Nov 23;7:1881
pubmed: 27933044
Clin Microbiol Infect. 2014 Oct;20(10):949-53
pubmed: 25040923
J Glob Antimicrob Resist. 2020 Dec;23:430-438
pubmed: 33176216
Lancet Infect Dis. 2015 Dec;15(12):1429-37
pubmed: 26482597
J Glob Antimicrob Resist. 2020 Sep;22:317-324
pubmed: 32247077
Asia Pac J Public Health. 2017 May;29(4):250-258
pubmed: 28569113
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Lancet Reg Health West Pac. 2021 Jan 23;7:100084
pubmed: 34327414
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702